Location:
Online
Reading Order:
1
Citation:
Development of a Pilot Scale Process for the Anti-Alzheimer Drug (−)-Galanthamine Using Large-Scale Phenolic Oxidative Coupling and Crystallisation-Induced Chiral Conversion
Bernhard Küenburg,†, Laszlo Czollner,†,§, Johannes Fröhlich,*,‡,‖ and, and Ulrich Jordis*,‡,
Organic Process Research & Development 1999 3 (6), 425-431